Devices & Diagnostics

Easily the best tweet from the JP Morgan Healthcare Conference (#jpm12)

There’s been an impressive amount of healthcare social media coming from the 2012 JP Morgan Healthcare Conference (impressive because, unlike their tech brethren, healthcare investors haven’t taken to social media). The best tidbits are always things overheard in the halls rather than at keynotes. And BioWorld Today has captured some perfect, irony-tinged insight: Eager consultant […]

By Chris Seper on January 11, 2012

Eager consultant overheard @ #JPM12: “We specialize in putting companies in front of the FDA”

2012 prediction: That consultant is going to be busy.

eBook

Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience

This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.

By Care Logistics

You can follow all the twitter commentary by following #jpm12.

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab